These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2617082

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus.
    Viallard JF, Pellegrin JL, Vergnes C, Borel-Derlon A, Clofent-Sanchez G, Nurden AT, Leng B, Nurden P.
    Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433
    [Abstract] [Full Text] [Related]

  • 27. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ, Pietu G, Rabinowitz R, Girma JP, Rogers J, Meyer D.
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [Abstract] [Full Text] [Related]

  • 28. Elevated granulocyte manganese in rheumatoid arthritis and other connective tissue diseases.
    Hällgren R, Svenson K, Johansson E, Lindh U.
    J Rheumatol; 1985 Oct; 12(5):876-80. PubMed ID: 4087268
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
    Lau CS, McLaren M, Hanslip J, Kerr M, Belch JJ.
    Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY, Freestone B, Lim HS, Kistorp C, Gustafsson F, Hildebrandt P, Lip GY.
    Int J Cardiol; 2007 Jun 25; 119(1):80-2. PubMed ID: 17027106
    [Abstract] [Full Text] [Related]

  • 38. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
    Lippi G, Franchini M, Targher G, Poli G, Guidi GC.
    Clin Chim Acta; 2007 Jun 25; 381(2):167-70. PubMed ID: 17433810
    [Abstract] [Full Text] [Related]

  • 39. Serum proteins--transferrin, ceruloplasmin, albumin, alpha 1-acid glycoprotein, alpha 1-antitrypsin--in rheumatic disorders.
    Denko CW, Gabriel P.
    J Rheumatol; 1979 Jun 25; 6(6):664-72. PubMed ID: 316826
    [Abstract] [Full Text] [Related]

  • 40. von Willebrand factor in synovial fluid.
    Bolosiu HD, Rus V, Parasca I, Dutu A, Malide D.
    Clin Exp Rheumatol; 1991 Jun 25; 9(4):395-8. PubMed ID: 1934689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.